Catalyst
Slingshot members are tracking this event:
Top-line Results from Mallinckrodt's (MNK) Pivotal Phase 3 Clinical Trial of StrataGraft Regenerative Tissue in Patients with Deep Partial-thickness Thermal Burns
Do you think this event is important to the companies below? How will it affect their stock price?
Related Companies | Importance
|
Impact on Stocks
|
||||
---|---|---|---|---|---|---|
MNK |
|
|
Additional Information
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 23, 2019
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Stratagraft, Thermal Burn Injury